EU: G20 leaders united to address major global pandemic, economic challenges


(MENAFN- Kuwait News Agency (KUNA)) BRUSSELS, Nov 22 (KUNA) -- The leaders of the world's 20 big economies, known as G20, Sunday agreed to make Covid-19 vaccines available and affordable for all following their two-day virtual summit hosted by Saudi Arabia.
"I am glad that G20 leaders agreed to make Covid-19 vaccines available and affordable for all. But more funding is needed. This is why I called G20 Leaders to commit to fund 4.5 billion US dollars for the ACT-Accelerator by the end of the year," President of the European Commission, Ursula von der Leyen said in a statement at the end of the meeting.
"G20 leaders also agreed to maintain economic measures until the recovery is firmly on the way. As a lesson from the crisis we need to step up global preparedness," she stated.
Von der Leyen, and President of the European Council, Charles Michel, represented the EU at the 15th G20 in virtual format to address the way forward how to tackle together the ongoing COVID-19 pandemic.
On his part, Michel said, "looking ahead, the global community has to be better prepared for pandemics. An international Treaty on Pandemics could help us respond more quickly and in a more coordinated manner when they occur."
"It should be negotiated with all UN organizations and agencies, in particular the WHO. The WHO must remain the cornerstone of global coordination against health emergencies," he noted.
G20 leaders also discussed a number of other crucial global issues such as the economic recovery, the reform of the WTO, the taxation of the digital economy and how to support low-income countries, said an EU press release. (end)
nk.mt




MENAFN22112020000071011013ID1101167290


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.